Victor van Beusechem

PROF.DR., (Principal Investigator)

1989 …2023

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile


oncolytic immunotherapy, therapeutic target discovery, high-throughput functional genomic screening, cancer therapy development

Research interests

The ultimate goal of the applied research in my laboratory is to make new, more effective medicines available for treatment of cancer patients. Towards this goal, two main strategies are followed.

Therapeutic target discovery: We perform high-throughput functional genomic screens with RNAi libraries to identify vulnerabilities in cancer cells. Next, we use validated leads from completed screens to discover new anticancer drugs and to design new treatment strategies.

Oncolytic immunotherapy: We apply molecular knowledge of cancer and viruses to develop next-generation oncolytic adenoviruses for personalized therapeutic vaccination. These viruses replicate in and kill cancer cells selectively, thereby inducing an adaptive immune response against released tumor antigens. We focus on promoting lytic replication and counteracting immune suppression in the tumor microenvironment.

Education/Academic qualification

PhD, Gene Therapy for Adenosine Deaminase Deficiency: Preclinical Studies, Leiden University, Leiden, Netherlands

Award Date: 16 Sep 1993

External positions

President, Netherlands Society of Gene and Cell Therapy

15 Mar 201831 Dec 2099

Chief Scientific Officer, ORCA Therapeutics

1 May 200831 Dec 2099


Recent external collaboration on country/territory level. Dive into details by clicking on the dots or